The treatment is for bowel cancer. (Image: Getty) A groundbreaking trial has discovered that two drugs typically used to strengthen immune systems can also help in the fight against bowel cancer when combined. Researchers at Anglia Ruskin University found that mixing botensilimab and balstilimab could help tackle the most common type of bowel cancer.
Their trial brings "new hope" for those battling the disease , as 61 percent of patients had their tumours shrunk by the new combination of drugs. The specific type of bowel cancer , microsatellite stable metastatic colorectal cancer (MSS mCRC), is notoriously resistant to other immunotherapies - utilising the immune system to fight cancer . function loadOvpScript(){let el=document.
createElement('script');el.setAttribute('src','https://live.primis.
tech/live/liveView.php?s=114945&playerApiId=v114945');document.getElementById('ovp-primis').
appendChild(el)}window.top.addEventListener('primisPlayerInit',e=>{try{if(e.
detail&&e.detail.playerApiId==="v114945"){if(window.
document.getElementsByClassName('jwplayer')[0]){e.detail.
float('disable')}}}catch(e){}});window.addEventListener('DOMContentLoaded',()=>{setTimeout(()=>{if(typeof flagTcfLoaded!=='undefined'&&flagTcfLoaded===!0){loadOvpScript()ExpressApp.Log('[Load] OVP flagTcfLoaded',new Date())}else{document.
addEventListener("tcfLoaded",()=>{loadOvpScript()ExpressApp.Log('[Load] OVP tcfLoaded',new Date())})}},1500)}) The authors of the study have called the treatment "potentially game-.
